Gene · 7049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction and Analysis of the Dysregulated ceRNA Network and Identification of Risk Long Noncoding RNAs in Breast Cancer. | Front Genet | 2021 | 34149805 | PubTator, text mining | PubMed |
| Using Tumor-Infiltrating Immune Cells and a ceRNA Network Model to Construct a Prognostic Analysis Model of Thyroid Carcinoma. | Front Oncol | 2021 | 34141614 | PubTator, text mining | PubMed |
| Inhibiting microRNA-424 in bone marrow mesenchymal stem cells-derived exosomes suppresses tumor growth in colorectal cancer by upregulating TGFBR3. | Arch Biochem Biophys | 2021 | 34129838 | PubTator, text mining | PubMed |
| Hsa_circ_0042823 accelerates cancer progression via miR-877-5p/FOXM1 axis in laryngeal squamous cell carcinoma. | Ann Med | 2021 | 34124974 | PubTator, text mining | PubMed |
| Hypoxia and Inflammation: Insights From High-Altitude Physiology. | Front Physiol | 2021 | 34122145 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis and screening of hub genes in papillary thyroid carcinoma. | PLoS One | 2021 | 34115774 | PubTator, text mining | PubMed |
| Omics Profiling of S2P Mutant Fibroblasts as a Mean to Unravel the Pathomechanism and Molecular Signatures of X-Linked MBTPS2 Osteogenesis Imperfecta. | Front Genet | 2021 | 34093655 | PubTator, text mining | PubMed |
| circRNA-TBC1D4, circRNA-NAALAD2 and circRNA-TGFBR3: Selected Key circRNAs in Neuroblastoma and Their Associations with Clinical Features. | Cancer Manag Res | 2021 | 34093041 | PubTator, text mining | PubMed |
| Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness. | Cancer Sci | 2021 | 34091990 | PubTator, text mining | PubMed |
| Exploration of Potential Genetic Biomarkers for Heart Failure: A Systematic Review. | Int J Environ Res Public Health | 2021 | 34072866 | PubTator, text mining | PubMed |
| Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing. | J Pers Med | 2021 | 34071035 | PubTator, text mining | PubMed |
| The Role of ZEB2 in Human CD8 T Lymphocytes: Clinical and Cellular Immune Profiling in Mowat-Wilson Syndrome. | Int J Mol Sci | 2021 | 34070208 | PubTator, text mining | PubMed |
| Contribution of Syndecans to the Cellular Entry of SARS-CoV-2. | Int J Mol Sci | 2021 | 34069441 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling. | Cells | 2021 | 34068954 | PubTator, text mining | PubMed |
| The Multifunctional Role of EMP3 in the Regulation of Membrane Receptors Associated with IDH-Wild-Type Glioblastoma. | Int J Mol Sci | 2021 | 34067658 | PubTator, text mining | PubMed |
| Poorly Differentiated Neuroendocrine Larynx Carcinoma: Clinical Features and miRNAs Signature-A New Goal for Early Diagnosis and Therapy? | J Clin Med | 2021 | 34066893 | PubTator, text mining | PubMed |
| Evidence of Cooperation between Hippo Pathway and RAS Mutation in Thyroid Carcinomas. | Cancers (Basel) | 2021 | 34065786 | PubTator, text mining | PubMed |
| Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis. | Cancers (Basel) | 2021 | 34065048 | PubTator, text mining | PubMed |
| MicroRNAs in Metastasis and the Tumour Microenvironment. | Int J Mol Sci | 2021 | 34064331 | PubTator, text mining | PubMed |
| CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines. | Front Oncol | 2021 | 34055629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7049/papers?page=44